# Thermo Fisher (TMO) — Analyst Forecast

TMO · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/tmo/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 24 | 6 | 0 | 30 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $580.00 | $699.71 | $760.00 | 7 |

Last price $696.49 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | $760.00 |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | $730.00 |
| Oct 7, 2026 | Barclays | Maintained | Overweight | $750.00 |
| Sep 9, 2026 | UBS | Initiated Coverage | Neutral → Buy | $730.00 |
| Sep 3, 2026 | CLSA | Initiated Coverage | Outperform | $748.00 |
| Jul 27, 2026 | Morgan Stanley | Maintained | Overweight | $650.00 |
| Jul 27, 2026 | Piper Sandler | Maintained | Neutral | $600.00 |
| Jul 24, 2026 | Barclays | Maintained | Overweight | $650.00 |
| Jul 24, 2026 | RBC Capital | Maintained | Sector Perform | $580.00 |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | $570.00 |
| Jun 26, 2026 | Bernstein | Maintained | Market Perform | $520.00 |
| Jun 11, 2026 | Piper Sandler | Initiated Coverage | Neutral | $510.00 |
| Jun 3, 2026 | HSBC | Downgraded | Buy → Hold | $540.00 |
| Jun 2, 2026 | Wolfe Research | Initiated Coverage | Outperform | $535.00 |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | $615.00 |
| Apr 24, 2026 | Stifel | Maintained | Buy | $600.00 |
| Apr 24, 2026 | Baird | Maintained | Outperform | $639.00 |
| Apr 14, 2026 | Barclays | Maintained | Overweight | $625.00 |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | $575.00 |
| Jan 30, 2026 | Barclays | Maintained | Overweight | $650.00 |

## Frequently Asked Questions

### What is the price target for TMO stock?

The average 12-month analyst price target for Thermo Fisher (TMO) is $699.71, with a high estimate of $760.00 and a low of $580.00, across 7 analysts.

### Is TMO a buy, sell, or hold?

Analysts covering Thermo Fisher currently average a Buy rating: 24 buy, 6 hold and 0 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for TMO?

The average price target of $699.71 implies 0.46% upside from the last price of $696.49.

### What is the latest analyst rating on TMO?

On Oct 13, 2026, TD Cowen maintained Thermo Fisher at Buy with a price target of $760.00.

## Similar Stocks

- [WST](https://www.lighthorse.io/tickers/wst) — West Pharmaceutical Services, Inc. Common Stock
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [BIO](https://www.lighthorse.io/tickers/bio) — Bio-Rad Laboratories, Inc. Class A Common Stock
- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock
- [QGEN](https://www.lighthorse.io/tickers/qgen) — Qiagen N.V. Common Shares
- [BIO.B](https://www.lighthorse.io/tickers/bio.b) — Bio-Rad Laboratories, Inc. Class B  Common Stock
- [ILMN](https://www.lighthorse.io/tickers/ilmn) — Illumina, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).